Skip to main content

Table 2 HSDS and ΔHSDS by diagnostic category.

From: Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®

 

HSDS

ΔHSDS

 

n

Mean (SD)

n

Mean (SD)

GHD

    

   Baseline

698

-2.22 (0.86)

-

-

   4 Months

698

-2.03 (0.82)

698

0.19 (0.33)

   Year 1

698

-1.61 (0.83)

698

0.61 (0.49)

   Year 2

697

-1.17 (0.88)

697

1.06 (0.64)

MPHD

    

   Baseline

71

-1.98 (1.36)

-

-

   4 Months

70

-1.62 (1.30)

70

0.37 (0.68)

   Year 1

70

-1.13 (1.04)

70

0.85 (0.76)

   Year 2

70

-0.79 (1.04)

70

1.20 (1.04)

Turner

    

   Baseline

60

-2.49 (0.77)

-

-

   4 Months

59

-2.32 (0.82)

59

0.18 (0.20)

   Year 1

60

-1.99 (0.86)

60

0.50 (0.31)

   Year 2

60

-1.68 (0.90)

60

0.82 (0.43)

SGA

    

   Baseline

50

-2.76 (0.97)

-

-

   4 Months

50

-2.48 (0.88)

50

0.28 (0.47)

   Year 1

50

-1.96 (0.93)

50

0.80 (0.59)

   Year 2

50

-1.59 (1.00)

50

1.18 (0.65)

ISS

    

   Baseline

123

-2.31 (0.68)

-

-

   4 Months

123

-2.16 (0.69)

123

0.15 (0.19)

   Year 1

123

-1.77 (0.69)

123

0.54 (0.38)

   Year 2

123

-1.41 (0.79)

123

0.90 (0.59)

  1. GHD, growth hormone deficiency; HSDS, height standard deviation score; ISS, idiopathic short stature; MPHD, multiple pituitary hormone deficiency; SD, standard deviation; SGA, small for gestational age.